JP2021516953A5 - - Google Patents

Info

Publication number
JP2021516953A5
JP2021516953A5 JP2020545324A JP2020545324A JP2021516953A5 JP 2021516953 A5 JP2021516953 A5 JP 2021516953A5 JP 2020545324 A JP2020545324 A JP 2020545324A JP 2020545324 A JP2020545324 A JP 2020545324A JP 2021516953 A5 JP2021516953 A5 JP 2021516953A5
Authority
JP
Japan
Prior art keywords
dna vector
dna
genes
polymerase
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020545324A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021516953A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/022511 external-priority patent/WO2019178500A1/en
Publication of JP2021516953A publication Critical patent/JP2021516953A/ja
Publication of JP2021516953A5 publication Critical patent/JP2021516953A5/ja
Priority to JP2023222352A priority Critical patent/JP2024041819A/ja
Pending legal-status Critical Current

Links

JP2020545324A 2018-03-15 2019-03-15 合成dnaベクターおよびその使用 Pending JP2021516953A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023222352A JP2024041819A (ja) 2018-03-15 2023-12-28 合成dnaベクターおよびその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862643336P 2018-03-15 2018-03-15
US62/643,336 2018-03-15
US201862749369P 2018-10-23 2018-10-23
US62/749,369 2018-10-23
PCT/US2019/022511 WO2019178500A1 (en) 2018-03-15 2019-03-15 Synthetic dna vectors and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023222352A Division JP2024041819A (ja) 2018-03-15 2023-12-28 合成dnaベクターおよびその使用

Publications (2)

Publication Number Publication Date
JP2021516953A JP2021516953A (ja) 2021-07-15
JP2021516953A5 true JP2021516953A5 (https=) 2022-03-23

Family

ID=67908049

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020545324A Pending JP2021516953A (ja) 2018-03-15 2019-03-15 合成dnaベクターおよびその使用
JP2023222352A Pending JP2024041819A (ja) 2018-03-15 2023-12-28 合成dnaベクターおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023222352A Pending JP2024041819A (ja) 2018-03-15 2023-12-28 合成dnaベクターおよびその使用

Country Status (10)

Country Link
US (2) US20210002667A1 (https=)
EP (1) EP3765023A4 (https=)
JP (2) JP2021516953A (https=)
KR (1) KR20200132893A (https=)
CN (2) CN117757842A (https=)
AU (1) AU2019233901A1 (https=)
CA (1) CA3092088A1 (https=)
IL (1) IL276923A (https=)
MX (1) MX2020009579A (https=)
WO (1) WO2019178500A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12403305B2 (en) 2016-06-27 2025-09-02 Galvanize Therapeutics, Inc. Immunostimulation in the treatment of viral infection
EP3474760B1 (en) 2016-06-27 2023-01-11 Galvanize Therapeutics, Inc. Generator and a catheter with an electrode for treating a lung passageway
US20200048716A1 (en) * 2017-11-03 2020-02-13 Twister Biotech, Inc Using minivectors to treat ovarian cancer
DK3731771T3 (da) 2017-12-26 2023-08-28 Galvanize Therapeutics Inc V462033dk00
SG11202103917VA (en) 2018-10-16 2021-05-28 Blueallele Llc Methods for targeted insertion of dna in genes
CN118203401A (zh) 2019-04-18 2024-06-18 盖能适治疗股份有限公司 用于治疗异常组织的装置、系统和方法
KR20220128607A (ko) 2019-09-18 2022-09-21 인터갈락틱 테라퓨틱스, 인크. 합성 dna 벡터 및 사용 방법
EP4192572A4 (en) 2020-08-04 2024-08-21 Galvanize Therapeutics, Inc. TRANSFER OF MOLECULES BY PULSED ELECTRIC FIELD TO CELLS IN THE ORGANISM
CN116829691A (zh) 2020-08-04 2023-09-29 盖能适治疗股份有限公司 分子到体内细胞的脉冲电场转移
EP4298214A4 (en) * 2021-02-23 2025-03-19 Aldevron, LLC NUCLEIC ACID VECTORS AND METHODS OF USE
CN118056012B (zh) * 2021-08-24 2025-05-30 赛斯尔擎生物技术(上海)有限公司 一种修饰细胞的方法
WO2023064934A1 (en) * 2021-10-15 2023-04-20 Intergalactic Therapeutics, Inc. Respiratory delivery of therapeutic agents
EP4522758A4 (en) * 2022-05-13 2026-05-06 Ascidian Therapeutics Inc Abca4 trans-splicing molecules
CA3262218A1 (en) 2022-07-19 2024-01-25 Rampart Bioscience, Inc. CIRCULAR NON-IMMUNOGENEOUS NON-VIRAL DNA VECTORS
WO2024039652A1 (en) * 2022-08-16 2024-02-22 Aldevron, L.L.C. Cell-free method of producing synthetic circular nucleic acid

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478745A (en) * 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
US6825012B2 (en) * 1995-02-23 2004-11-30 Gencell S.A. DNA molecules, preparation and use in gene therapy
RU2001135838A (ru) * 1999-05-28 2004-01-20 Камбрекс Байо Сайенс Инк. (Us) Способы очистки ДНК и очищенная ДНК
EP1224313A1 (en) * 1999-10-07 2002-07-24 University of Iowa Research Foundation Adeno-associated viruses and uses thereof
AU2001288839A1 (en) * 2000-09-08 2002-03-22 The General Hospital Corporation Self-rearranging dna vectors
US20070196838A1 (en) * 2000-12-08 2007-08-23 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
AU2002247014A1 (en) * 2001-01-19 2002-07-30 Genetica, Inc. Methods and reagents for amplification and manipulation of vector and target nucleic acid sequences
AU2009231171A1 (en) * 2008-04-02 2009-10-08 Fondazione Telethon Method of treating genetic disorders
US8236548B2 (en) * 2008-07-03 2012-08-07 The Board Of Trustees Of The Leland Stanford Junior University Minicircle DNA vector preparations and methods of making and using the same
US8945885B2 (en) * 2008-07-03 2015-02-03 The Board Of Trustees Of The Leland Stanford Junior University Minicircle DNA vector preparations and methods of making and using the same
EP2439276A1 (de) * 2010-10-05 2012-04-11 Rentschler Biotechnologie GmbH Verfahren zur semi-synthetischen Herstellung hochreiner "MiniCircle" DNA-Vektoren aus Plasmiden
EP2500434A1 (en) * 2011-03-12 2012-09-19 Association Institut de Myologie Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
US20140350087A9 (en) * 2012-03-22 2014-11-27 Halozyme, Inc. Oncovector Nucleic Acid Molecules and Methods of Use
EP2994531B1 (en) * 2013-05-10 2018-03-28 Sangamo Therapeutics, Inc. Delivery methods and compositions for nuclease-mediated genome engineering
WO2016120186A1 (en) * 2015-01-27 2016-08-04 F. Hoffmann-La Roche Ag Recombinant hbv cccdna, the method to generate thereof and the use thereof
EP3294309A4 (en) * 2015-05-14 2019-01-16 St. Jude Children's Research Hospital, Inc. NUCLEIC ACID MOLECULES WITH SPACERS AND METHOD FOR USE THEREOF
CA3005474A1 (en) * 2015-11-19 2017-05-26 The Trustees Of The University Of Pennsylvania Compositions and methods for correction of heritable ocular disease
MX2018010633A (es) * 2016-03-03 2019-06-13 Univ Massachusetts Acido desoxirribonucleico (adn) lineal duplex de extremos cerrados para transferencia genica no viral.
KR20220128607A (ko) * 2019-09-18 2022-09-21 인터갈락틱 테라퓨틱스, 인크. 합성 dna 벡터 및 사용 방법

Similar Documents

Publication Publication Date Title
JP2021516953A5 (https=)
JP2022549138A5 (https=)
JP2022517174A5 (https=)
JP2023126487A5 (https=)
CN112154208B (zh) 产生改进的病毒和非病毒纳米质粒载体
EP3242903B1 (en) Compositions for introducing nucleic acid into cells
ES2344078T3 (es) Arnm estabilizado con un contenido de g/c aumentado para la terapia genetica.
JP2019524149A5 (https=)
JP2025061660A (ja) Rna誘導型エンドヌクレアーゼを使用するdna組み込みのための改善された方法
JP2018527013A5 (https=)
JP2021516953A (ja) 合成dnaベクターおよびその使用
GB2643666A (en) Linear dna with enhanced resistance against exonucleases and methods for the production thereof
WO1994009127A2 (en) Supercoiled minicircle dna as as a unitary promoter vector
JP2023511991A5 (https=)
JP2023526310A5 (https=)
JP2024516272A (ja) エキソヌクレアーゼに対する増加した耐性を有する直鎖状dna
US20250223592A1 (en) Compositions and methods for circular rna affinity purification
JP2024502620A5 (https=)
WO2024015803A9 (en) Encrypted rna and methods of its use
WO2018139637A1 (ja) 核酸封入aav中空粒子
CN113950530A (zh) 核酸多联体产物的表达
CN115806984A (zh) 环状rna及载体和载体的应用
US12116578B2 (en) Methods and systems of PCR-based recombinant adeno-associated virus manufacture
JP7642824B2 (ja) 遺伝子発現および抑制が同時に可能な核酸構造体
JP7575761B2 (ja) 核酸封入aav中空粒子の製造方法